Given its role in pain and inflammation, Substance P is a target for various therapeutic interventions. For instance, NK1 receptor antagonists are being explored for treating chronic pain conditions, migraines, and certain inflammatory diseases. Additionally, understanding the distribution and function of Substance P can aid in the development of new diagnostic and therapeutic strategies for neurogenic inflammation and pain management.
